Live
ePaper
Search
Home > India > BRIEF-Allarity Therapeutics Expands Phase 2 Stenoparib Trial To Three Ovarian Cancer Patient Cohorts

BRIEF-Allarity Therapeutics Expands Phase 2 Stenoparib Trial To Three Ovarian Cancer Patient Cohorts

Written By:
Last Updated: November 16, 2026 19:22:04 IST

Nov 16 (Reuters) – Allarity Therapeutics Inc: * ALLARITY THERAPEUTICS EXPANDS PHASE 2 STENOPARIB TRIAL TO THREE OVARIAN CANCER PATIENT COHORTS Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?